Jason M. Melear
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
- Co-authors
- Jeff P. Sharman (23 shared papers)John M. Burke (16 shared papers)Habte Yimer (13 shared papers)Suzanne Fanning (23 shared papers)Thomas S. Lin (5 shared papers)Marlon F. Levy (1 shared paper)Kathryn S. Kolibaba (17 shared papers)Edward A. Faber (5 shared papers)
- Journals
- Blood (19 papers)Journal of Clinical Oncology (12 papers)Hematological Oncology (6 papers)HemaSphere (3 papers)Annals of Oncology (3 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Jason M. Melear
52 papers receiving 349 citations
Peers
Comparison fields: 5 of 47
- Hematology 131
- Genetics 92
- Oncology 203
- Pathology and Forensic Medicine 109
- Hepatology 35
Countries citing papers authored by Jason M. Melear
This map shows the geographic impact of Jason M. Melear's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason M. Melear with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason M. Melear more than expected).
Fields of papers citing papers by Jason M. Melear
This network shows the impact of papers produced by Jason M. Melear. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason M. Melear. The network helps show where Jason M. Melear may publish in the future.
Co-authors
The 25 scholars most cited alongside Jason M. Melear, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 50 | |
| 2 | 2019 | 49 | |
| 3 | 2021 | 26 | |
| 4 | 2019 | 16 | |
| 5 | 2019 | 14 | |
| 6 | 2020 | 13 | |
| 7 | 2021 | 11 | |
| 8 | 2017 | 11 | |
| 9 | 2022 | 10 | |
| 10 | 2017 | 10 | |
| 11 | 2019 | 9 | |
| 12 | 2018 | 9 | |
| 13 | 2020 | 8 | |
| 14 | 2020 | 8 | |
| 15 | 2015 | 7 | |
| 16 | 2016 | 7 | |
| 17 | 2024 | 6 | |
| 18 | 2021 | 6 | |
| 19 | 2017 | 6 | |
| 20 | 2019 | 6 |
About Jason M. Melear
Jason M. Melear is a scholar working on Genetics, Oncology, Pathology and Forensic Medicine, Hematology and Pulmonary and Respiratory Medicine, having authored 56 papers that have together received 354 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (28 papers), Lymphoma Diagnosis and Treatment (24 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Multiple Myeloma Research and Treatments (9 papers), CAR-T cell therapy research (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). The work is most often cited by research in Hematology (131 citations), Genetics (92 citations), Oncology (203 citations), Pathology and Forensic Medicine (109 citations) and Hepatology (35 citations). Jason M. Melear has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Jeff P. Sharman, John M. Burke, Habte Yimer, Suzanne Fanning, Thomas S. Lin, Marlon F. Levy, Kathryn S. Kolibaba, Edward A. Faber, David Andorsky and William Bensinger. Their work appears in journals such as Blood, Journal of Clinical Oncology, Hematological Oncology, HemaSphere and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.